22 July 2019

Allen & Gledhill advised PanAsia Health Limited (“PanAsia Health”), which is indirectly controlled by EQT Mid Market Asia III GP B.V., acting in its capacity as general partner of EQT Mid Market Asia III Limited Partnership (“EQT”), and Nam See Investment (Pte) Ltd. (“Nam See Investment”), the founding family and substantial shareholder of Health Management International Ltd (“HMI”), as transaction counsel, on the S$611 million proposed acquisition of all shares in HMI by way of a scheme of arrangement.

Advising PanAsia Health and EQT were Allen & Gledhill Partners Christopher Koh and Wong Yi Jia.

Advising Nam See Investment were Allen & Gledhill Partners Song Su-Min and Chiam Tao Koon.

More

A&G News 11 September 2025

Allen & Gledhill named FinTech and Digital Assets Firm of the Year at the Asia Legal Awards 2025

Read more

A&G News 25 August 2025

A&G Asia recognised in Lexology Index’s Southeast Asia 2025 guide

Read more